🇺🇸 Humulin L in United States

664 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Blood Glucose Increased — 179 reports (26.96%)
  2. Blood Glucose Decreased — 123 reports (18.52%)
  3. Malaise — 48 reports (7.23%)
  4. Nausea — 48 reports (7.23%)
  5. Hypoglycaemia — 47 reports (7.08%)
  6. Pharmaceutical Product Complaint — 46 reports (6.93%)
  7. Drug Ineffective — 44 reports (6.63%)
  8. Blood Glucose Fluctuation — 43 reports (6.48%)
  9. Loss Of Consciousness — 43 reports (6.48%)
  10. Vomiting — 43 reports (6.48%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Humulin L approved in United States?

Humulin L does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Humulin L in United States?

Sanofi is the originator. The local marketing authorisation holder may differ — check the official source linked above.